The University of Washington Institute for Protein Design (IPD) was founded in 2012 under the leadership of David Baker. The institute integrates biochemistry, engineering, computer science and medicine, and leverages Seattle's ecosystem and expertise and software and machine learning to solve problems in medicine, materials and energy.
Investors 1
| Date | Name | Website |
| - | Sahsen Ven... | sahsen.com |
Mentions in press and media 18
| Date | Title | Description | Source |
| 17.08.2023 | The 30 young leaders who are forging a new future for the he... | Your browser does not support the video element. This story is available exclusively to Insider subs... | businessin... |
| 10.07.2023 | How AI is changing the way scientists engineer drugs, biosen... | RF Diffusion, a deep learning tool, was prompted to generate a new protein (orange) that binds to th... | geekwire.c... |
| 01.02.2023 | A scientist is using AI to design a nasal spray that could p... | David Baker runs the Institute for Protein Design at the University of Washington. Ian C Haydon/UW I... | businessin... |
| 29.08.2022 | Sneaky synthetic molecules open the way for new types of dru... | An illustration shows how custom-made peptide molecules (shown in pink and purple) can slip through ... | geekwire.c... |
| 15.08.2022 | Institute for Protein Design spinout Monod Bio raises $25M f... | Monod Bio co-founders, from left: David Shoultz, Daniel-Adriano Silva, and Alfredo Quijano Rubio. (M... | geekwire.c... |
| 09.06.2022 | David Baker, head of Seattle’s Institute for Protein Design,... | IPD director David Baker. (IPD Photo) Prolific biotech co-founder and University of Washington scien... | geekwire.c... |
| 12.04.2022 | Health Innovation of the Year: 5 finalists at the GeekWire A... | Finalists for the 2022 GeekWire Health Innovation of the Year. The finalists for Health Innovation o... | geekwire.c... |
| 31.01.2022 | Gandeeva Therapeutics raises $40m zoom in on biomolecules – ... | The field scientists once jokingly called “blobography” has come a long way. Cryogenic electron micr... | techcrunch... |
| 07.07.2021 | Seattle-based Icosavax, which is developing COVID-19 vaccine... | Icosavax creates virus-like particles with technology licensed from the University of Washington’s I... | geekwire.c... |
| 07.04.2021 | Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine... | Icosavax creates virus-like particles with technology licensed from the University of Washington’s I... | geekwire.c... |
Show more